SONX Stock Overview A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Sonendo, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Sonendo Historical stock prices Current Share Price US$2.20 52 Week High US$80.00 52 Week Low US$1.00 Beta 1.14 1 Month Change -37.14% 3 Month Change -70.82% 1 Year Change -96.33% 3 Year Change -99.83% 5 Year Change n/a Change since IPO -99.88%
Recent News & Updates
Sonendo, Inc. Launches ProControl for the G4 System Oct 25
Sonendo, Inc. Revises Guidance for the Fiscal Year 2024 Oct 11 Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended June 30, 2024
Sonendo, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 25 Sonendo, Inc. Announces the Appointment of John Bostjancic as Chief Financial Officer Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024 May 10
See more updates
Sonendo, Inc. Launches ProControl for the G4 System Oct 25
Sonendo, Inc. Revises Guidance for the Fiscal Year 2024 Oct 11 Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended June 30, 2024
Sonendo, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 25 Sonendo, Inc. Announces the Appointment of John Bostjancic as Chief Financial Officer Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024 May 10
Sonendo, Inc., Annual General Meeting, Jun 10, 2024 May 01
Sonendo, Inc. to Report Q1, 2024 Results on May 08, 2024 Apr 26
NYSE Intends to Apply to SEC for Delisting of the Sonendo's Common Stock Apr 16
Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023 Mar 14 Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023
Sonendo, Inc. Announces CFO Changes Mar 10
Sonendo, Inc. Announces CFO Changes Mar 09 Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million. Mar 06
Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million. Mar 05
Sonendo, Inc. to Report Fiscal Year 2023 Results on Mar 11, 2024 Mar 02
Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024 Feb 16
Sonendo Announces Suspension of NYSE Trading, to Commence Trading on the OTCQX Effective November 22, 2023 Nov 23 Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023
Price target decreased by 14% to US$1.67 Nov 12
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18% Nov 10
Third quarter 2023 earnings: EPS misses analyst expectations Nov 10
Sonendo, Inc. to Report Q3, 2023 Results on Nov 08, 2023 Oct 26
Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2023 Oct 11 Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule Oct 05
Sonendo, Inc. Announces Launch of Second Generation CleanFlow Procedure Instrument for Heightened Efficacy and Ease of Use Sep 29
Price target decreased by 15% to US$2.65 Aug 13
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Aug 10
Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023 Aug 10
Sonendo, Inc.'s Enhanced CleanFlow Procedure Instrument Now Indicated for Use on Anterior Teeth Aug 03
Price target decreased by 7.5% to US$3.10 Jul 12
Sonendo, Inc. Announces the Publication of New Study That Found the GentleWave System to Be Significantly More Effective Than Conventional Irrigation Methods at Dissolving TissueDissolution During Root Canal Procedures Jun 28
New minor risk - Insider selling Jun 25
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 10
Sonendo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2023 May 10
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price Apr 19
Insider recently bought US$80k worth of stock Mar 22
Full year 2022 earnings: EPS and revenues exceed analyst expectations Mar 09
Sonendo, Inc. to Report Q4, 2022 Results on Mar 08, 2023 Feb 16
Sonendo unit PIPStek files patent infringement lawsuit against Biolase Jan 04
Insider recently bought US$56k worth of stock Dec 13
Price target decreased to US$3.67 Nov 16
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 12
Sonendo, Inc. Provides Revenue Guidance for the Year 2022 Nov 10
GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M Nov 09
Sonendo Announces Health Canada Regulatory Approval for Next Generation GentleWave G4 System Nov 02
Sonendo, Inc. to Report Q3, 2022 Results on Nov 09, 2022 Oct 20
Sonendo® Announces Release of GentleWave® G4 System Oct 19
Consensus forecasts updated Oct 05 Sonendo, Inc. announced that it has received $62.999997 million in funding from ArrowMark Colorado Holdings, LLC Sep 29
Sonendo, Inc. announced that it expects to receive $62.999997 million in funding from ArrowMark Colorado Holdings, LLC Sep 24
Sonendo announces $63 million private placement Sep 23
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 11
Sonendo, Inc. Expects Revenue Guidance for Full Year 2022 Aug 11
Sonendo, Inc. to Report Q2, 2022 Results on Aug 10, 2022 Jul 20
President recently bought US$64k worth of stock Jun 19
Sonendo, Inc. Announces Executive Management Team Changes Jun 18
Insider recently bought US$133k worth of stock May 17
Sonendo, Inc. Provides Revenue Guidance for the Year 2022 May 12
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 11
Sonendo Announces Launch of Cleanflow™ Technology to Improve Doctor and Patient Experience Apr 21
Sonendo, Inc. to Report Q1, 2022 Results on May 10, 2022 Apr 20
Cory A. Eaves and Paul S. Madera Not to Stand for Re-Election as Directors of Sonendo, Inc Apr 14
Sonendo, Inc. to Report Q4, 2021 Results on Mar 23, 2022 Mar 04
Sonendo, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2021 Jan 12
Third quarter 2021 earnings: EPS and revenues exceed analyst expectations Dec 12
Sonendo: Painful Debut For This Dental Play Nov 07
Less than half of directors are independent Nov 01 Shareholder Returns SONX US Medical Equipment US Market 7D 5.8% -1.2% -2.7% 1Y -96.3% 10.0% 23.4%
See full shareholder returns
Return vs Market: SONX underperformed the US Market which returned 23.4% over the past year.
Price Volatility Is SONX's price volatile compared to industry and market? SONX volatility SONX Average Weekly Movement 33.5% Medical Equipment Industry Average Movement 7.7% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.9% 10% least volatile stocks in US Market 3.2%
Stable Share Price: SONX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SONX's weekly volatility has increased from 24% to 33% over the past year.
About the Company Founded Employees CEO Website 2006 208 Bjarne Bergheim sonendo.com
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Show more Sonendo, Inc. Fundamentals Summary How do Sonendo's earnings and revenue compare to its market cap? SONX fundamental statistics Market cap US$937.76k Earnings (TTM ) -US$36.90m Revenue (TTM ) US$41.66m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) SONX income statement (TTM ) Revenue US$41.66m Cost of Revenue US$24.60m Gross Profit US$17.06m Other Expenses US$53.96m Earnings -US$36.90m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -86.57 Gross Margin 40.94% Net Profit Margin -88.58% Debt/Equity Ratio 154.0%
How did SONX perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 11:01 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Sonendo, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Michael Cherny BofA Global Research Vadim Merkulov Freedom Broker Nathan Rich Goldman Sachs
Show 1 more analysts 
